Compounds > fangchinoline
Page last updated: 2024-08-25

fangchinoline and Melanoma

fangchinoline has been researched along with Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bao, K; Jia, R; Li, B; Li, J; Li, R; Li, Y; Mao, F; Shi, J; Wei, J; Yang, J; Zhu, J1
Chang, P; Guo, B; Hui, Q; Shi, J; Tao, K1
Chen, C; Hu, S; Huang, L; Lan, J; Lin, C; Liu, Y; Lou, H; Pan, W; Xia, B; Zeng, X1

Other Studies

3 other study(ies) available for fangchinoline and Melanoma

ArticleYear
Fangchinoline suppresses conjunctival melanoma by directly binding FUBP2 and inhibiting the homologous recombination pathway.
    Cell death & disease, 2021, 04-07, Volume: 12, Issue:4

    Topics: Benzylisoquinolines; Conjunctival Neoplasms; Drugs, Chinese Herbal; Female; Homologous Recombination; Humans; Male; Melanoma

2021
Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK.
    Oncology reports, 2017, Volume: 38, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Cell Movement; Cell Proliferation; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Phosphorylation; Signal Transduction; Tumor Cells, Cultured

2017
Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives.
    Molecules (Basel, Switzerland), 2017, Nov-08, Volume: 22, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; K562 Cells; Melanoma

2017